February 20, 2007 (Denver) — Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) seem to slow down the increased solute transport that occurs with long-term ...
A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...
Morning Overview on MSN
A common blood-pressure pill may be quietly speeding kidney damage in diabetics
Three large randomized trials tested a simple idea: if one blood-pressure drug that blocks the renin-angiotensin system ...
kidney Risk of mortality in HF patients with reduced kidney function taking ACE inhibitors and ARBs were evaluated. WASHINGTON, DC—According to data presented at the ACC.17 Scientific Session, ...
Do ACE inhibitors or angiotensin II receptor blockers (ARBs) offer renal protection to patients with diabetes or renal disease?— Negeen Farmand, PA-C, Los Angeles When should a clinician stop an ACE ...
Low blood pressure, or hypotension, in COVID-19 patients with a history of hypertension appears to be a risk factor for kidney damage and death. Reducing hypertension medications if and when COVID-19 ...
"The clear answer is that ACE inhibitors and ARBs pose no increased risk as compared to other treatments." While other studies have generated similar findings recently, this study is the most ...
Credit: Getty Images. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines. Angiotensin receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results